Opus Genetics Inc (NASDAQ: IRD) Not A Good Play Anymore?
Opus Genetics Inc (IRD) concluded trading on Thursday at a closing price of $1.02, with 9.48 million shares of worth about $9.67 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 4.24% during that period and on June 26, 2025 the price saw a […]
Opus Genetics Inc (NASDAQ: IRD) – Suitable For Long Term Buy?
Currently, there are 45.48M common shares owned by the public and among those 39.42M shares have been available to trade. The company’s stock has a 5-day price change of 6.86% and 12.16% over the past three months. IRD shares are trading -8.40% year to date (YTD), with the 12-month market performance down to -36.07% lower. […]